Raichem Medicare Profile
Key Indicators
- Authorised Capital ₹ 26.70 Cr
as on 29-06-2024
- Paid Up Capital ₹ 1.74 Cr
as on 29-06-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.00 Cr
as on 29-06-2024
- Satisfied Charges ₹ 80.00 Cr
as on 29-06-2024
- Revenue 10.91%
(FY 2023)
- Profit -42.58%
(FY 2023)
- Ebitda 4.14%
(FY 2023)
- Net Worth 53.50%
(FY 2023)
- Total Assets 12.18%
(FY 2023)
About Raichem Medicare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 26.70 Cr and a paid-up capital of Rs 1.74 Cr.
The company currently has active open charges totaling ₹12.00 Cr. The company has closed loans amounting to ₹80.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Enzo Bartoli, Agostino Barazza, and Pramod Kumar serve as directors at the Company.
- CIN/LLPIN
U24232KA2009PTC049999
- Company No.
049999
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2009
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Chicksugur Village, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Raichem Medicare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Kumar  | Managing Director | 05-Dec-2015 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Enzo Bartoli  | Director | 30-Jan-2012 | Current |
| Agostino Barazza | Director | 02-Sep-2020 | Current |
Financial Performance and Corporate Structure Insights of Raichem Medicare.
Raichem Medicare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.91% increase. The company also saw a substantial fall in profitability, with a 42.58% decrease in profit. The company's net worth Soared by an impressive increase of 53.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raichem Medicare?
In 2023, Raichem Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 06 Apr 2023 | ₹10.00 Cr | Open |
Citi Bank N.A. Creation Date: 15 Sep 2015 | ₹2.00 Cr | Open |
Citi Bank N.A. Creation Date: 03 Jun 2015 | ₹20.00 Cr | Satisfied |
How Many Employees Work at Raichem Medicare?
Raichem Medicare has a workforce of 210 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jan 29, 2019, Raichem Medicare has raised a total of ₹ 69.17 Cr, with the most recent deal valued at ₹ 24.7 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
